Create stunning visuals effortlessly with Google Gemini 2.0. Explore text-to-image, editing tools, and custom designs powered ...

IceCure Medical Ltd.  ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

3.Poster Presentation (Abstract #1011): 1)Title: A Deep Learning-Based IHC Tumor Cellular Membranous Staining Analysis for PD-L1 Assessment in Non-Small Cell Lung Cancer 2)Poster Board #: 215 3 ...

Event organizers often overlook the visa-related difficulties that researchers in low- and middle-income countries face. This must change.

Oral Presentation Poster Presentation About Zentalis Pharmaceuticals Zentalis ® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially ...

(“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will feature two oral presentations, one poster presentation, and chair a symposium ...

("Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will feature two oral presentations, one poster presentation, and chair a symposium at the .

It's a win-win, and it's why everything on iStock is only available royalty-free — including all Abstract images and footage. What kinds of royalty-free files are available on iStock? How can you use ...

PRINCETON, N.J., Feb. 26, 2025 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET HORIZON trial of rocatinlimab, an investigational therapy targeting ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for Avtozma ® (CT-P47), a biosimilar referencing RoActemra ® (tocilizumab). Avtozma ® has been ...

INCHEON, SOUTH KOREA – Celltrion today announced that the European Commission (EC) has granted marketing authorization for Avtozma ® (CT-P47), a biosimilar referencing RoActemra ® (tocilizumab).